W-JHS NHL02-A study

JRCT ID: jRCT1071210120

Registered date:23/01/2022

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Peripheral T-cell lymphoma (including extranodal NK/T-cell lymphoma)
• Date of first enrollment: 25/04/2019
• Target sample size: 20
• Study type: Observational

Outcome(s)

• Primary Outcome: Gene and protein expression, gene mutation, lymphocyte subset analysis, serum cytokine and chemokine, HLA gene, single cell analysis
• Secondary Outcome: Nothing

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1) Patients enrolled in W-JHS NHL02 study (jRCT2071210101)
2) Patients providing the written informed consent.
3) Patients whose specimens for any test in 'biomarker exploration' can be submitted

• Exclude criteria: Nothing particular

Related Information

• Primary Sponsor: Akashi Koichi
• Source(s) of Monetary Support: Ono Pharmaceutical Co., Ltd.
• Secondary ID(s): UMIN000034502